Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tae Min Kim

Showing results (151-160 of 588) with videos related to

Pageof 59
Sort By:
Cancer Science|November 24, 2011
Influence of chemotherapy on nitric oxide synthase, indole-amine-2,3-dioxygenase and CD124 expression in granulocytes and monocytes of non-small cell lung cancerSung Hoon Sim, Yong-Oon Ahn, Jieun Yoon, et al.
Cancer Research and Treatment|October 13, 2018
Acquired Resistance of MET-Amplified Non-small Cell Lung Cancer Cells to the MET Inhibitor CapmatinibSeulki Kim, Tae Min Kim, Dong-Wan Kim, et al.
Diagnostic Pathology|June 22, 2024
Transformation of t(14;18)-negative follicular lymphoma to plasmablastic lymphoma: a case report with analysis of genetic evolutionSojung Lim, Jiwon Koh, Jeong Mo Bae, et al.
Chemical Communications (Cambridge, England)|September 2, 2020
Cancer cell death using metabolic glycan labelling techniquesSang-Hyun Park, Hyoje Jung, Hosoowi Lee, et al.
Virchows Archiv : an International Journal of Pathology|September 7, 2016
Expression of programmed cell death ligand 1 (PD-L1) in advanced stage EBV-associated extranodal NK/T cell lymphoma is associated with better prognosisWook Youn Kim, Ho Young Jung, Soo Jeong Nam, et al.
Lung Cancer (Amsterdam, Netherlands)|March 14, 2007
CD63 as a biomarker for predicting the clinical outcomes in adenocarcinoma of lungMi Seon Kwon, Seung-Hun Shin, Seon-Hee Yim, et al.
Experimental & Molecular Medicine|October 16, 2021
Human kidney organoids reveal the role of glutathione in Fabry diseaseJin Won Kim, Hyung Wook Kim, Sun Ah Nam, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 26, 2011
MicroRNA-146a downregulates NFκB activity via targeting TRAF6 and functions as a tumor suppressor having strong prognostic implications in NK/T cell lymphomaJin Ho Paik, Ji-Young Jang, Yoon Kyung Jeon, et al.
Virchows Archiv : an International Journal of Pathology|March 15, 2020
Clinicopathological features of programmed cell death-1 and programmed cell death-ligand-1 expression in the tumor cells and tumor microenvironment of angioimmunoblastic T cell lymphoma and peripheral T cell lymphoma not otherwise specifiedSehui Kim, Dohee Kwon, Jiwon Koh, et al.
The Korean Journal of Internal Medicine|April 14, 2017
KRAS G12C mutation as a poor prognostic marker of pemetrexed treatment in non-small cell lung cancerSehhoon Park, Ji-Yeon Kim, Se-Hoon Lee, et al.
Pageof 59

Showing results (151-160 of 588) with videos related to

Sort By:
Pageof 59
Cancer Science|November 24, 2011
Influence of chemotherapy on nitric oxide synthase, indole-amine-2,3-dioxygenase and CD124 expression in granulocytes and monocytes of non-small cell lung cancerSung Hoon Sim, Yong-Oon Ahn, Jieun Yoon, et al.
Cancer Research and Treatment|October 13, 2018
Acquired Resistance of MET-Amplified Non-small Cell Lung Cancer Cells to the MET Inhibitor CapmatinibSeulki Kim, Tae Min Kim, Dong-Wan Kim, et al.
Diagnostic Pathology|June 22, 2024
Transformation of t(14;18)-negative follicular lymphoma to plasmablastic lymphoma: a case report with analysis of genetic evolutionSojung Lim, Jiwon Koh, Jeong Mo Bae, et al.
Chemical Communications (Cambridge, England)|September 2, 2020
Cancer cell death using metabolic glycan labelling techniquesSang-Hyun Park, Hyoje Jung, Hosoowi Lee, et al.
Virchows Archiv : an International Journal of Pathology|September 7, 2016
Expression of programmed cell death ligand 1 (PD-L1) in advanced stage EBV-associated extranodal NK/T cell lymphoma is associated with better prognosisWook Youn Kim, Ho Young Jung, Soo Jeong Nam, et al.
Lung Cancer (Amsterdam, Netherlands)|March 14, 2007
CD63 as a biomarker for predicting the clinical outcomes in adenocarcinoma of lungMi Seon Kwon, Seung-Hun Shin, Seon-Hee Yim, et al.
Experimental & Molecular Medicine|October 16, 2021
Human kidney organoids reveal the role of glutathione in Fabry diseaseJin Won Kim, Hyung Wook Kim, Sun Ah Nam, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 26, 2011
MicroRNA-146a downregulates NFκB activity via targeting TRAF6 and functions as a tumor suppressor having strong prognostic implications in NK/T cell lymphomaJin Ho Paik, Ji-Young Jang, Yoon Kyung Jeon, et al.
Virchows Archiv : an International Journal of Pathology|March 15, 2020
Clinicopathological features of programmed cell death-1 and programmed cell death-ligand-1 expression in the tumor cells and tumor microenvironment of angioimmunoblastic T cell lymphoma and peripheral T cell lymphoma not otherwise specifiedSehui Kim, Dohee Kwon, Jiwon Koh, et al.
The Korean Journal of Internal Medicine|April 14, 2017
KRAS G12C mutation as a poor prognostic marker of pemetrexed treatment in non-small cell lung cancerSehhoon Park, Ji-Yeon Kim, Se-Hoon Lee, et al.
Pageof 59